WSJ Headline: Moderna’s Covid-19 Vaccine Targeting Omicron Produces Stronger Immune Response
Subheadline: Experimental vaccine, designed to fight Omicron and original virus, found to be more effective against new variant than current shot
By Peter LoftusFollow
June 8, 2022 7:00 am ET
Moderna Inc. said a modified Covid-19 booster shot provided a stronger immune response than the company’s original vaccine against the Omicron variant in a new study.
The Cambridge, Mass., company said Wednesday it will submit preliminary data from the study to U.S. health regulators in the coming weeks with the hope of making the modified booster shot available in late summer.
Researchers found that the levels of neutralizing antibodies against Omicron among people getting the modified shot were 1.75 times higher than in people who received a booster shot of the original vaccine, Moderna said.